Suprane Patient Counseling Information

Anesthesia providers need to obtain the following information from patients prior to administration of anesthesia: Medications they are taking, including herbal supplements; Drug allergies, including allergic reactions to anesthetic agents (including hepatic sensitivity); Any history of severe reactions to prior administration of anesthetic; If the patient or a member of the patient's family has a history of malignant hyperthermia or if the patient has a history of Duchenne muscular dystrophy or other latent neuromuscular disease.
Anesthesia providers should inform patients of the risks associated with SUPRANE: Post-operative nausea and vomiting and respiratory adverse effects including coughing.
There is no information of the effects of SUPRANE following anesthesia on the ability to operate an automobile or other heavy machinery. However, patients should be advised that the ability to perform such tasks may be impaired after receiving anesthetic agents.
Anesthesia providers should inform parents and caregivers of pediatric patients that emergence from anesthesia in children may evoke a brief state of agitation that may hinder cooperation.
Effect of anesthetic and sedation drugs on early brain development: Studies conducted in young animals and children suggest repeated or prolonged use of general anesthetic or sedation drugs in children younger than 3 years may have negative effects on their developing brains. Discuss with parents and caregivers the benefits, risks, and timing and duration of surgery or procedures requiring anesthetic and sedation drugs [see Pediatric Neurotoxicity under Precautions].